Filter
35
Text search:
selective
serotonin
reuptake
inhibitors
Featured
Recommendations
6
New Publications
5
Language
Document type
No document type
28
Manuals
3
Training Material
2
Studies & Reports
1
Guidelines
1
Countries / Regions
India
2
Nepal
1
South Sudan
1
Syria
1
South Africa
1
Global
1
Authors & Publishers
Publication Years
Category
Clinical Guidelines
4
Countries
3
Public Health
2
Capacity Building
1
Key Resources
1
Toolboxes
Mental Health
24
HIV
1
COVID-19
1
Pharmacy
1
This guide was developed by AACAP to give reliable information about medication
used to treat bipolar disorder in children and adolescents to parents whose children
have been diagnosed with the illness.
Q7. SCOPING QUESTION: In adults with moderate-severe depressive disorder, what is the effectiveness and safety of antidepressant medication (ADM) in comparison with psychological treatment?
The WHO mhGAP programme’s existing guidelines recommend that either structured brief psychological treatm
...
Introduction
Capter A.1
Ethics and international child and adolescent psychiatry
The new guide provides practical, first-line management recommendations for mental, neurological and substance use conditions. Contents include modules on assessing and managing conditions such as acute stress, grief, moderate-severe depressive disorder, post-traumatic stress disorder, epilepsy, and
...
Accessed January 22, 2019.
This updated version include important research that has added to our knowledge about effective treatments for
child and adolescent depression. Its goal is to help parents and families make informed decisions about getting the best care for a child with depression. For
...
This joint publication by UNAIDS and WHO emphasizes the importance of integrating HIV prevention, testing, treatment and care and mental health services for people living with HIV. It provides a compilation of tools, best practices, recommendations and guidelines that facilitate the integration of i
...
Anxiety disorders
Chapter F.3
20 February 2013
Update on 2004 Background Paper (Written by Saloni Tanna)
Priority Medicines for Europe and the World "A Public Health Approach to Innovation"
Disease Control Priorities, 3rdEdition: Volume 4.
Mental, neurological, and substance use disorders are common, highly disabling, and associated with significant premature mortality. The impact of these disorders on the social and economic well-beingof individuals, families, and societies is large
...
• provide scientific information on the safety, efficacy, and quality control/ quality assurance of widely used medicinal plants, in order to facilitate their appropriate use in Member States;
• provide models to assist Member States in developing their own mono- graphs or formularies for these
...
Third edition
